Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 185

Results For "TN"

2848 News Found

Kiran Mazumdar-Shaw awarded H. K. Firodia Lifetime Achievement Award 2022
People | September 26, 2022

Kiran Mazumdar-Shaw awarded H. K. Firodia Lifetime Achievement Award 2022

The committee unanimously decided to confer the Lifetime Achievement Award to Kiran Mazumdar-Shaw for her monumental contributions as a global leader in biotechnology innovation and entrepreneurship


Aptar Pharma collaborates with Fluidda
News | September 25, 2022

Aptar Pharma collaborates with Fluidda

The companies will leverage their respective proprietary technology platforms


India achieves significant landmark in reduction of child mortality rates
Policy | September 24, 2022

India achieves significant landmark in reduction of child mortality rates

The country has been witnessing a progressive reduction in IMR, U5MR and NMR


Bausch and Glenmark announce approval of RYALTRIS in Canada
Drug Approval | September 24, 2022

Bausch and Glenmark announce approval of RYALTRIS in Canada

RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray


KRSNAA leverages AI to deliver quality diagnostics to the rural hinterlands of India
Healthcare | September 23, 2022

KRSNAA leverages AI to deliver quality diagnostics to the rural hinterlands of India

Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune


Aster Hospitals Bangalore launches 'Aster International Institute of Oncology'
Healthcare | September 22, 2022

Aster Hospitals Bangalore launches 'Aster International Institute of Oncology'

This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.


Aster Pharmacy forays into Bangladesh
Healthcare | September 22, 2022

Aster Pharmacy forays into Bangladesh

Aster Pharmacy will be operated by GD Assist Limited in Bangladesh.


Quinten Health closes its financing round to advance disease modeling platforms
News | September 21, 2022

Quinten Health closes its financing round to advance disease modeling platforms

Quinten Health will announce in the coming months strategic partnerships with big pharma companies and data owners to launch the first disease modeling platforms.


Merck to initiate new Phase 3 clinical program for treatment of HIV-1 Infection
Clinical Trials | September 21, 2022

Merck to initiate new Phase 3 clinical program for treatment of HIV-1 Infection

Phase 2 study evaluating an investigational weekly oral combination treatment regimen of islatravir and Gilead Sciences’ lenacapavir to resume with lower dose of islatravir